Scott Otallah to Clinical Trials as Topic
This is a "connection" page, showing publications Scott Otallah has written about Clinical Trials as Topic.
Connection Strength
0.289
-
Waubant E, Banwell B, Wassmer E, Sormani MP, Amato MP, Hintzen R, Krupp L, Rostásy K, Tenembaum S, Chitnis T. Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG. Neurology. 2019 05 28; 92(22):e2538-e2549.
Score: 0.289